Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Oluchi C Ukaegbu
Concurrent B-Cell Follicular and Refractory CD30+ Large Cell Transformation of Mycosis Fungoides Responsive to Rituximab and Brentuximab Vedotin
Journal of Blood Disorders & Transfusion
Related publications
Oral Mycosis Fungoides With CD30+ Large Cell Transformation Successfully Treated With Brentuximab Vedotin
JAAD Case Reports
Dermatology
A Case of Refractory Sézary Syndrome With Large-Cell Transformation Responsive to Brentuximab Vedotin
JAMA Dermatology
Dermatology
Medicine
Brentuximab as a Treatment for CD30+Mycosis Fungoides and Sézary Syndrome
JAMA Dermatology
Dermatology
Medicine
Response to Brentuximab Vedotin by Cd30 Expression: Results From Five Trials in Ptcl, Ctcl, and B-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Cost-Effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
Journal of Health Economics and Outcomes Research
Targeted Drug Brentuximab Vedotin for Treatment of Relapsed or Refractory Cd30-Positive Hodgkin’s Lymphoma
Malignant tumours
Brentuximab Vedotin for Relapsed or Refractory CD30+ Hodgkin Lymphoma: A Multicenter Analysis From Asia
OncoTargets and Therapy
Oncology
Pharmacology
CD30 Expression and Proliferative Fraction in Nontransformed Mycosis Fungoides
American Journal of Surgical Pathology
Anatomy
Forensic Medicine
Pathology
Surgery
Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Medical Journal Armed Forces India
Medicine